[go: up one dir, main page]

RU95112464A - Способ получения производных таксана - Google Patents

Способ получения производных таксана

Info

Publication number
RU95112464A
RU95112464A RU95112464/04A RU95112464A RU95112464A RU 95112464 A RU95112464 A RU 95112464A RU 95112464/04 A RU95112464/04 A RU 95112464/04A RU 95112464 A RU95112464 A RU 95112464A RU 95112464 A RU95112464 A RU 95112464A
Authority
RU
Russia
Prior art keywords
ris
formula
hydrogen atom
iii
taxane derivatives
Prior art date
Application number
RU95112464/04A
Other languages
English (en)
Inventor
Бурза Жан-Доминик
Fr]
Коммерсон Ален
Депрез Доминик
Пюликани Жан-Пьер
Original Assignee
Рон-Пуленк Роре С.А. (FR)
Рон-Пуленк Роре С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рон-Пуленк Роре С.А. (FR), Рон-Пуленк Роре С.А. filed Critical Рон-Пуленк Роре С.А. (FR)
Publication of RU95112464A publication Critical patent/RU95112464A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/20—Processes
    • C25B3/25—Reduction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B11/00—Electrodes; Manufacture thereof not otherwise provided for
    • C25B11/04—Electrodes; Manufacture thereof not otherwise provided for characterised by the material
    • C25B11/042—Electrodes formed of a single material
    • C25B11/046—Alloys
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B9/00—Cells or assemblies of cells; Constructional parts of cells; Assemblies of constructional parts, e.g. electrode-diaphragm assemblies; Process-related cell features
    • C25B9/17—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof
    • C25B9/19—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms
    • C25B9/23—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms comprising ion-exchange membranes in or on which electrode material is embedded

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Metallurgy (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)

Abstract

Изобретение относится к способу получения производных таксана общей формулы I электрохимическим путем из производного таксана общей формуле III. Формулы I и III приведены в описании.

Claims (1)

  1. Изобретение относится к способу получения производных таксана общей формулы I электрохимическим путем из производного таксана общей формуле III. Формулы I и III приведены в описании.
RU95112464/04A 1992-11-12 1993-11-10 Способ получения производных таксана RU95112464A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9213586A FR2697841B1 (fr) 1992-11-12 1992-11-12 Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR9213586 1992-11-12

Publications (1)

Publication Number Publication Date
RU95112464A true RU95112464A (ru) 1997-02-20

Family

ID=9435452

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95112464/04A RU95112464A (ru) 1992-11-12 1993-11-10 Способ получения производных таксана

Country Status (15)

Country Link
EP (1) EP0667922A1 (ru)
JP (1) JPH08503261A (ru)
KR (1) KR950704540A (ru)
AU (1) AU5425794A (ru)
CA (1) CA2149240A1 (ru)
CZ (1) CZ122495A3 (ru)
FI (1) FI952294L (ru)
FR (1) FR2697841B1 (ru)
MX (1) MX9306883A (ru)
NO (1) NO951772D0 (ru)
PL (1) PL308957A1 (ru)
RU (1) RU95112464A (ru)
SK (1) SK60895A3 (ru)
WO (1) WO1994011547A1 (ru)
ZA (1) ZA938366B (ru)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
FR2710642B1 (fr) * 1993-09-29 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2711369B1 (fr) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
ATE196844T1 (de) * 1996-05-22 2000-10-15 Protarga Inc Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
CA3031283A1 (en) * 2004-01-22 2005-08-04 University Of Miami Topical co-enzyme q10 formulations and methods of use
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
EA201101519A1 (ru) 2009-05-11 2012-10-30 БЕРГ БАЙОСИСТЕМЗ, ЭлЭлСи Способы диагностики метаболических нарушений, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
CN103608323B (zh) 2011-04-04 2016-08-17 博格有限责任公司 治疗中枢神经系统肿瘤的方法
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
NZ713868A (en) 2013-04-08 2021-12-24 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
HUE050060T2 (hu) 2013-09-04 2020-11-30 Berg Llc Eljárások rák kezelésére koenzim Q10 folyamatos infúziójával

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
PL308957A1 (en) 1995-09-04
NO951772L (no) 1995-05-05
FR2697841A1 (fr) 1994-05-13
FI952294A0 (fi) 1995-05-11
JPH08503261A (ja) 1996-04-09
CA2149240A1 (fr) 1994-05-26
NO951772D0 (no) 1995-05-05
SK60895A3 (en) 1996-03-06
MX9306883A (es) 1995-01-31
CZ122495A3 (en) 1995-12-13
ZA938366B (en) 1994-06-13
KR950704540A (ko) 1995-11-20
FI952294L (fi) 1995-05-11
FR2697841B1 (fr) 1995-01-13
AU5425794A (en) 1994-06-08
WO1994011547A1 (fr) 1994-05-26
EP0667922A1 (fr) 1995-08-23

Similar Documents

Publication Publication Date Title
RU95112464A (ru) Способ получения производных таксана
CZ145595A3 (en) Novel taxoids, process of their preparation and pharmaceutical compositions containing thereof
RU95110686A (ru) Способ получения производных таксана, промежуточные соединения для их синтеза
DE69304309D1 (de) Verfahren zur herstellung von taxan-derivaten
PL310441A1 (en) Novel taxoides, method of obtaining them and pharmaceutical compositions containing such compounds
RU94041682A (ru) Способ получения производных таксана
AU2309695A (en) Process for preparing 7-trialkylsilyl baccatin iii
KR880005145A (ko) N-글리코릴네우라민산 함유 당지질 및 그 제조방법
ATE26258T1 (de) Herstellung von phenylalaninen durch hydrierung von phenylserinen.
ATE30718T1 (de) Herstellung von 1-benzyl azetidin-3-ol und von dem entsprechenden halid acid.
AU2309795A (en) Process for the preparation of 7-hydroxy taxanes
RU95113420A (ru) Способы получения 1,3-оксазолидин-5-карбоновой кислоты